Citius Pharmaceuticals Inc (NASDAQ:CTXR) does about 2.15M shares in volume on a normal day but saw 2914854 shares change hands in the recent trading day. The company now has a market cap of 12.07M USD. Its current market price is $2150000.0, marking an increase of 2914854% compared to the previous close of $0.91. The 52 week high reached by this stock is $26.25 whilst the lowest price level in 52 weeks is $0.65.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential downside of -42999900.0% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 30, 2024 when D. Boral Capital upgraded the stock to “Buy” and issued a price target of $9.
The current price level is 24.78%, 27.45%, and -75.67% away from its SMA20, SMA50, and SMA200 respectively, with the CTXR price moving above the 50-day SMA on current market day. Citius Pharmaceuticals Inc (CTXR) stock is up 17.39% over the week and 46.22% over the past month. Its price is -92.99% year-to-date and -73.00% over the past year.
To reach the target analysts have set, the stock logically needs to shrink -42999900.0 percent from here.
The company has a return on investment of -70.14% and return on equity of -60.06%. The forward price to earnings ratio is 2.89. The beta has a value of 0.84. Price to book ratio is 0.16.
